Edgewell Personal Care (EPC) Financials

$22.36 -0.47 (-2.06%)

Closing price 05/6/2026 03:59 PM Eastern

Extended Trading

$20.12 -2.24 (-10.01%)

As of 04:36 AM Eastern

Annual Income Statements for Edgewell Personal Care

This table shows Edgewell Personal Care's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	9/30/2015	9/30/2016	9/30/2017	9/30/2018	9/30/2019	9/30/2020	9/30/2021	9/30/2022	9/30/2023	9/30/2024	9/30/2025
Net Income / (Loss) Attributable to Common Shareholders	-275	179	5.70	103	570	68	118	100	115	99	25
Consolidated Net Income / (Loss)	-275	179	5.70	103	-372	68	118	100	115	99	25
Net Income / (Loss) Continuing Operations	-296	179	5.70	103	570	68	118	100	115	99	25
Total Pre-Tax Income	-459	220	-53	164	-390	87	147	124	148	121	24
Total Operating Income	-199	295	-1.10	215	244	176	240	182	227	199	97
Total Gross Profit	1,184	1,160	1,126	1,033	967	881	951	881	941	956	925
Total Revenue	2,421	2,362	2,298	2,234	2,141	1,950	2,087	2,172	2,252	2,254	2,224
Operating Revenue	2,421	2,362	2,298	2,234	2,141	1,950	2,087	2,172	2,252	2,254	2,224
Total Cost of Revenue	1,237	1,202	1,173	1,202	1,174	1,069	1,136	1,291	1,311	1,298	1,299
Operating Cost of Revenue	1,237	1,202	1,173	1,202	1,174	1,069	1,136	1,291	1,311	1,298	1,299
Total Operating Expenses	1,383	865	1,127	818	351	705	711	698	714	756	828
Selling, General & Admin Expense	572	413	393	395	-	409	391	389	410	430	425
Marketing Expense	367	337	318	293	251	216	242	238	229	232	247
Research & Development Expense	71	72	68	61	54	55	58	56	59	58	58
Impairment Charge	318	6.50	319	24	-	-	-	-	0.00	0.00	51
Restructuring Charge	55	37	30	39	46	25	21	15	17	36	48
Total Other Income / (Expense), net	-260	-75	-52	-51	-64	-89	-93	-58	-79	-78	-73
Interest Expense	100	72	69	68	63	87	94	71	79	77	73
Other Income / (Expense), net	-81	-3.40	17	17	-1.50	-1.30	1.20	13	-0.80	-1.90	0.20
Income Tax Expense	-163	41	-59	61	-18	20	29	25	33	22	-1.80
Basic Earnings per Share	($4.44)	$3.02	$0.10	$1.90	($6.88)	$1.25	$2.17	$1.87	$2.24	$1.98	$0.53
Weighted Average Basic Shares Outstanding	62M	59.20M	57.30M	54.40M	54.21M	54.36M	54.37M	51.44M	51.20M	49.70M	47.50M
Diluted Earnings per Share	($4.44)	$2.99	$0.10	$1.90	($6.88)	$1.24	$2.13	$1.85	$2.21	$1.97	$0.53
Weighted Average Diluted Shares Outstanding	62M	59.20M	57.30M	54.40M	54.21M	54.36M	54.37M	51.44M	51.80M	50.10M	47.60M
Weighted Average Basic & Diluted Shares Outstanding	62M	59.20M	57.30M	54.40M	54.21M	54.36M	54.37M	51.44M	50.02M	48.72M	46.46M
Cash Dividends to Common per Share	$1.50	-	-	-	-	-	-	-	-	$0.60	$0.60

This table shows Edgewell Personal Care's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025
Net Income / (Loss) Attributable to Common Shareholders	53	30	4.80	36	49	8.80	-2.10	29	29	-31	-66
Consolidated Net Income / (Loss)	53	30	4.80	36	49	8.80	-2.10	29	29	-31	-66
Net Income / (Loss) Continuing Operations	53	30	4.80	36	49	8.80	-10	29	29	-31	-29
Total Pre-Tax Income	71	33	6.00	47	63	5.40	-13	41	37	-53	-37
Total Operating Income	86	52	26	70	83	20	9.30	59	54	-36	-19
Total Gross Profit	280	229	198	258	287	213	173	256	269	209	161
Total Revenue	650	534	489	599	648	518	415	581	627	537	423
Operating Revenue	650	534	489	599	648	518	415	581	627	537	423
Total Cost of Revenue	370	306	291	341	361	305	243	325	359	329	262
Operating Cost of Revenue	370	306	291	341	361	305	243	325	359	329	262
Total Operating Expenses	194	177	172	188	204	192	163	197	215	245	180
Selling, General & Admin Expense	96	112	103	108	110	109	100	106	104	112	102
Marketing Expense	80	40	48	63	77	44	46	66	80	51	46
Research & Development Expense	15	16	13	14	15	16	13	14	14	16	14
Restructuring Charge	3.00	7.90	6.80	3.20	3.10	23	4.10	12	16	16	18
Total Other Income / (Expense), net	-15	-19	-20	-23	-20	-15	-22	-18	-17	-17	-18
Interest Expense	19	19	20	20	19	18	19	20	19	15	19
Other Income / (Expense), net	3.80	-0.10	-0.30	-2.70	-1.40	2.50	-3.20	2.60	2.90	-2.10	1.30
Income Tax Expense	18	3.40	1.20	11	14	-3.40	-2.60	12	8.10	-23	-7.70
Net Income / (Loss) Discontinued Operations	-	-	-	-	-	-	8.00	-	-	-	-37
Basic Earnings per Share	$1.04	$0.58	$0.10	$0.72	$0.99	$0.17	($0.04)	$0.60	$0.62	($0.65)	($1.41)
Weighted Average Basic Shares Outstanding	50.81M	50.02M	50.10M	49.80M	49.50M	48.72M	48.70M	48M	46.80M	47.50M	46.60M
Diluted Earnings per Share	$1.02	$0.58	$0.09	$0.72	$0.98	$0.18	($0.04)	$0.60	$0.62	($0.65)	($1.41)
Weighted Average Diluted Shares Outstanding	50.81M	50.02M	50.50M	50.20M	50.10M	48.72M	48.70M	48.20M	47M	47.60M	46.60M
Weighted Average Basic & Diluted Shares Outstanding	50.81M	50.02M	49.93M	49.55M	49.31M	48.72M	48.23M	47.03M	46.46M	46.46M	46.72M
Cash Dividends to Common per Share	$0.15	-	-	$0.15	-	-	$0.15	$0.15	-	-	$0.15

This table details how cash moves in and out of Edgewell Personal Care's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	9/30/2015	9/30/2016	9/30/2017	9/30/2018	9/30/2019	9/30/2020	9/30/2021	9/30/2022	9/30/2023	9/30/2024	9/30/2025
Net Change in Cash & Equivalents	-417	27	-236	-237	75	23	115	-291	27	2.40	17
Net Cash From Operating Activities	149	187	314	259	191	233	229	102	-216	-231	118
Net Cash From Continuing Operating Activities	149	187	314	259	191	233	229	102	216	231	118
Net Income / (Loss) Continuing Operations	-275	179	5.70	103	-372	68	118	100	115	99	25
Consolidated Net Income / (Loss)	-275	179	5.70	103	-372	68	118	100	115	99	25
Depreciation Expense	115	93	94	98	94	89	87	90	91	88	89
Non-Cash Adjustments To Reconcile Net Income	521	27	324	41	582	44	54	25	38	27	78
Changes in Operating Assets and Liabilities, net	-212	-111	-110	18	-113	33	-30	-113	-28	17	-73
Net Cash From Investing Activities	-175	-70	-85	-119	-46	-196	-49	-355	-51	-62	-73
Net Cash From Continuing Investing Activities	-175	-70	-85	-119	-46	-196	-49	-355	-43	-49	-73
Purchase of Property, Plant & Equipment	-99	-70	-69	-62	-58	-48	-57	-56	-50	-57	-77
Other Investing Activities, net	14	-	0.00	9.70	8.40	2.90	0.90	5.40	6.40	7.30	4.10
Net Cash From Financing Activities	-327	-93	-478	-380	-64	-19	-65	-18	-147	-179	-30
Net Cash From Continuing Financing Activities	-327	-93	-478	-380	-64	-19	-65	-18	-147	-179	-30
Repayment of Debt	-2,168	-653	-586	-798	-509	-67	-526	-556	-872	-896	-840
Repurchase of Common Equity	-175	-197	-165	-124	0.00	0.00	-9.20	-125	-75	-59	-90
Payment of Dividends	-93	-	-	-	0.00	0.00	-26	-33	-32	-31	-29
Issuance of Debt	2,604	756	273	550	440	50	500	707	841	813	937
Other Financing Activities, net	-500	-	-	-7.50	5.40	-2.00	-4.20	-11	-9.00	-7.30	-7.50
Effect of Exchange Rate Changes	-64	2.90	13	2.50	-6.10	5.60	-0.40	-20	-	-	1.10
Cash Interest Paid	164	71	66	67	61	56	61	68	74	63	73
Cash Income Taxes Paid	55	28	14	22	58	25	25	24	46	34	26

This table details how cash moves in and out of Edgewell Personal Care's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025
Net Change in Cash & Equivalents	35	27	-10	-18	-0.10	13	-34	-5.40	30	26	-2.40
Net Cash From Operating Activities	166	48	-73	129	101	74	-116	45	115	74	-126
Net Cash From Continuing Operating Activities	161	55	-73	129	101	74	-116	45	115	74	-126
Net Income / (Loss) Continuing Operations	53	30	4.80	36	49	8.80	-2.10	29	29	-31	-66
Consolidated Net Income / (Loss)	53	30	4.80	36	49	8.80	-2.10	29	29	-31	-66
Depreciation Expense	23	23	23	22	22	21	22	22	22	23	21
Non-Cash Adjustments To Reconcile Net Income	6.60	17	7.10	6.40	7.20	6.50	7.50	6.40	6.60	57	45
Changes in Operating Assets and Liabilities, net	79	-15	-107	64	23	37	-143	-12	57	25	-126
Net Cash From Investing Activities	-12	-19	-6.00	-14	-17	-26	-16	-17	-12	-28	-9.90
Net Cash From Continuing Investing Activities	-12	-23	-7.00	-14	-17	-26	-16	-17	-12	-28	-9.90
Purchase of Property, Plant & Equipment	-12	-18	-6.50	-12	-13	-26	-17	-17	-16	-28	-12
Other Investing Activities, net	0.70	-4.50	-0.50	-2.20	-4.60	0.40	1.10	-0.20	3.20	-	1.70
Net Cash From Financing Activities	-103	-14	70	-129	-80	-40	110	-37	-83	-19	133
Net Cash From Continuing Financing Activities	-100	-14	70	-129	-80	-40	110	-37	-83	-19	133
Repayment of Debt	-323	-158	-126	-106	-693	-197	152	5.60	-47	-949	-151
Repurchase of Common Equity	-15	-30	-15	-15	-9.90	-18	-30	-35	-25	-	0.00
Payment of Dividends	-7.70	-7.70	-7.60	-8.20	-7.50	-7.40	-7.90	-7.30	-7.20	-6.90	-7.40
Issuance of Debt	237	191	220	-0.20	631	182	3.70	-0.20	-4.30	937	294
Other Financing Activities, net	8.70	-9.60	-2.20	-	-0.10	-0.20	-7.30	-0.10	-	-0.10	-2.80
Effect of Exchange Rate Changes	-	-	-	-4.10	-4.20	4.90	-12	4.20	10	-1.30	0.00

This table presents Edgewell Personal Care's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	9/30/2015	9/30/2016	9/30/2017	9/30/2018	9/30/2019	9/30/2020	9/30/2021	9/30/2022	9/30/2023	9/30/2024	9/30/2025
Total Assets	4,986	4,772	4,189	3,953	3,421	3,541	3,675	3,713	3,741	3,731	3,756
Total Current Assets	1,637	1,452	1,186	951	1,044	984	1,136	942	962	936	996
Cash & Equivalents	712	739	503	266	342	365	479	189	216	209	226
Accounts Receivable	280	261	224	227	206	159	151	137	106	109	138
Inventories, net	333	309	334	330	357	314	346	449	492	477	434
Prepaid Expenses	312	143	126	129	140	146	160	167	147	140	139
Other Current Nonoperating Assets	-	-	-	-	-	-	-	-	-	-	60
Plant, Property, & Equipment, net	499	486	453	424	396	371	363	346	338	349	295
Total Noncurrent Assets	2,851	2,833	2,549	2,578	1,981	2,186	2,176	2,425	2,440	2,446	2,466
Goodwill	1,422	1,420	1,446	1,451	1,033	1,160	1,163	1,322	1,331	1,339	1,137
Intangible Assets	1,409	1,385	1,072	1,099	913	928	906	997	974	949	828
Other Noncurrent Operating Assets	21	28	32	28	35	99	107	107	135	159	179
Other Noncurrent Nonoperating Assets	-	-	-	-	-	-	-	-	-	-	322
Total Liabilities & Shareholders' Equity	4,986	4,772	4,189	3,953	3,421	3,541	3,675	3,713	3,741	3,731	3,756
Total Liabilities	3,122	2,943	2,447	2,209	2,117	2,108	2,090	2,246	2,200	2,147	2,203
Total Current Liabilities	667	868	524	717	660	511	537	540	523	564	566
Short-Term Debt	18	300	19	193	131	21	27	19	20	25	30
Accounts Payable	237	197	224	238	223	182	210	229	194	219	220
Other Current Liabilities	412	371	281	286	305	308	301	292	310	320	311
Other Current Nonoperating Liabilities	-	-	-	-	-	-	-	-	-	-	5.20
Total Noncurrent Liabilities	2,455	2,074	1,923	1,492	1,458	1,598	1,554	1,707	1,677	1,583	1,638
Long-Term Debt	1,699	1,544	1,525	1,104	1,098	1,238	1,234	1,391	1,361	1,275	1,383
Noncurrent Deferred & Payable Income Tax Liabilities	336	255	182	176	101	103	129	140	136	133	119
Other Noncurrent Operating Liabilities	421	275	216	212	259	257	190	175	180	175	136
Total Equity & Noncontrolling Interests	1,864	1,829	1,742	1,745	1,304	1,433	1,584	1,467	1,541	1,584	1,553
Total Preferred & Common Equity	1,864	1,829	1,742	1,745	1,304	1,433	1,584	1,467	1,541	1,584	1,553
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	1,864	1,829	1,742	1,745	1,304	1,433	1,584	1,467	1,541	1,584	1,553
Common Stock	1,645	1,643	1,624	1,629	1,628	1,633	1,632	1,605	1,595	1,587	1,580
Retained Earnings	773	946	953	1,083	715	782	866	939	1,022	1,090	1,087
Treasury Stock	-382	-563	-704	-819	-804	-790	-776	-861	-906	-938	-1,003
Accumulated Other Comprehensive Income / (Loss)	-172	-197	-131	-148	-236	-192	-137	-216	-170	-155	-110

This table presents Edgewell Personal Care's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025	Q3 2025	Q1 2026
Period end date	6/30/2022	3/31/2023	6/30/2023	12/31/2023	3/31/2024	6/30/2024	12/31/2024	3/31/2025	6/30/2025	12/31/2025
Total Assets	3,721	3,799	3,766	3,787	3,756	3,708	3,702	3,773	3,793	3,768
Total Current Assets	934	1,009	989	1,006	995	959	945	1,012	1,005	1,057
Cash & Equivalents	182	155	207	214	196	196	176	170	200	223
Accounts Receivable	155	161	122	113	131	155	121	178	153	154
Inventories, net	414	541	503	522	496	456	502	512	488	461
Prepaid Expenses	183	153	157	157	172	152	148	152	164	162
Other Current Nonoperating Assets	-	-	-	-	-	-	-	-	-	57
Plant, Property, & Equipment, net	348	342	340	334	328	325	343	345	356	293
Total Noncurrent Assets	2,440	2,447	2,438	2,448	2,434	2,424	2,415	2,416	2,433	2,418
Goodwill	1,332	1,334	1,336	1,337	1,334	1,333	1,329	1,333	1,343	1,137
Intangible Assets	1,011	990	984	970	960	952	934	930	929	822
Other Noncurrent Operating Assets	97	123	118	141	140	139	152	153	161	179
Other Noncurrent Nonoperating Assets	-	-	-	-	-	-	-	-	-	280
Total Liabilities & Shareholders' Equity	3,721	3,799	3,766	3,787	3,756	3,708	3,702	3,773	3,793	3,768
Total Liabilities	2,243	2,292	2,215	2,241	2,205	2,132	2,201	2,259	2,225	2,282
Total Current Liabilities	575	569	580	468	542	535	459	536	567	498
Short-Term Debt	19	22	18	24	24	21	27	27	23	33
Accounts Payable	239	245	241	198	220	209	204	216	225	213
Other Current Liabilities	317	302	321	246	299	305	228	294	320	248
Other Current Nonoperating Liabilities	-	-	-	-	-	-	-	-	-	4.00
Total Noncurrent Liabilities	1,668	1,723	1,635	1,774	1,663	1,597	1,742	1,723	1,658	1,784
Long-Term Debt	1,357	1,414	1,323	1,452	1,351	1,290	1,441	1,433	1,373	1,521
Noncurrent Deferred & Payable Income Tax Liabilities	138	142	142	137	136	137	133	133	134	118
Other Noncurrent Operating Liabilities	173	167	170	185	176	169	169	157	152	145
Total Equity & Noncontrolling Interests	1,478	1,507	1,551	1,546	1,551	1,577	1,501	1,514	1,568	1,486
Total Preferred & Common Equity	1,478	1,507	1,551	1,546	1,551	1,577	1,501	1,514	1,568	1,486
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	1,478	1,507	1,551	1,546	1,551	1,577	1,501	1,514	1,568	1,486
Common Stock	1,601	1,584	1,587	1,570	1,575	1,582	1,563	1,568	1,574	1,561
Retained Earnings	906	946	991	1,019	1,048	1,089	1,081	1,102	1,124	1,014
Treasury Stock	-847	-864	-876	-897	-911	-921	-945	-979	-1,004	-985
Accumulated Other Comprehensive Income / (Loss)	-182	-160	-151	-147	-160	-173	-198	-177	-127	-105

This table displays calculated financial ratios and metrics derived from Edgewell Personal Care's official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	9/30/2015	9/30/2016	9/30/2017	9/30/2018	9/30/2019	9/30/2020	9/30/2021	9/30/2022	9/30/2023	9/30/2024	9/30/2025
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-7.31%	-2.45%	-2.69%	-2.78%	-4.18%	-8.94%	7.06%	4.04%	3.68%	0.09%	-1.34%
EBITDA Growth	-140.97%	333.90%	-71.19%	197.56%	2.03%	-21.60%	24.55%	-13.04%	11.28%	-10.14%	-34.97%
EBIT Growth	-205.59%	204.33%	-94.41%	1,322.09%	4.53%	-27.90%	38.01%	-18.91%	15.70%	-12.73%	-50.96%
NOPAT Growth	-165.00%	272.07%	-100.32%	17,717.17%	25.81%	-20.14%	40.97%	-23.92%	20.61%	-7.80%	-36.04%
Net Income Growth	-177.31%	164.91%	-96.81%	1,712.28%	-460.31%	118.16%	74.26%	-15.53%	15.28%	-14.04%	-74.24%
EPS Growth	-178.03%	167.34%	-96.66%	1,800.00%	-462.11%	118.02%	71.77%	-13.15%	19.46%	-10.86%	-73.10%
Operating Cash Flow Growth	-73.99%	25.54%	67.88%	-17.28%	-26.52%	22.04%	-1.55%	-55.46%	111.86%	6.90%	151.26%
Free Cash Flow Firm Growth	-49.59%	-74.30%	-13.32%	-4.05%	423.52%	-99.98%	83,297.14%	-215.19%	190.92%	19.63%	-80.10%
Invested Capital Growth	-22.10%	2.32%	-5.15%	-0.31%	-21.04%	6.21%	1.66%	13.65%	0.58%	-1.10%	2.46%
Revenue Q/Q Growth	107.47%	2.18%	-1.95%	-1.22%	-0.44%	-1.97%	2.68%	-0.29%	-0.12%	-0.73%	0.89%
EBITDA Q/Q Growth	-658.84%	11,745.45%	-74.12%	505.51%	233.90%	-68.96%	7.01%	-0.38%	-3.08%	-9.80%	-24.28%
EBIT Q/Q Growth	-172.78%	409.33%	-95.12%	637.82%	170.35%	-76.97%	10.85%	-1.36%	-4.48%	-12.85%	-38.77%
NOPAT Q/Q Growth	-94.24%	500.22%	-100.30%	400.45%	170.52%	-78.61%	15.83%	-9.15%	0.34%	-12.53%	-13.97%
Net Income Q/Q Growth	-1,036.39%	292.15%	-97.24%	260.16%	5.41%	-22.57%	25.45%	-9.38%	-3.94%	-17.63%	-60.80%
EPS Q/Q Growth	-1,044.68%	289.24%	-97.24%	259.66%	5.36%	-22.98%	25.29%	-7.96%	-3.07%	-16.88%	-61.03%
Operating Cash Flow Q/Q Growth	-31.43%	44.58%	-1.29%	-27.96%	8.23%	10.24%	-15.15%	-29.90%	9.20%	12.63%	0.34%
Free Cash Flow Firm Q/Q Growth	-41.89%	-71.81%	-41.01%	-31.34%	202.94%	-99.98%	381.44%	1.16%	-1.65%	8.04%	-21.66%
Invested Capital Q/Q Growth	-23.13%	-3.99%	-8.94%	-0.95%	-5.17%	10.18%	1.43%	0.62%	0.74%	-0.66%	-0.87%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	48.89%	49.11%	48.99%	46.23%	45.15%	45.18%	45.57%	40.54%	41.78%	42.41%	41.60%
EBITDA Margin	-6.79%	16.27%	4.82%	14.74%	15.70%	13.51%	15.72%	13.14%	14.11%	12.66%	8.35%
Operating Margin	-8.22%	12.49%	-0.05%	9.63%	11.39%	9.03%	11.49%	8.39%	10.08%	8.84%	4.34%
EBIT Margin	-11.55%	12.35%	0.71%	10.37%	11.32%	8.96%	11.55%	9.00%	10.05%	8.76%	4.35%
Profit (Net Income) Margin	-11.37%	7.57%	0.25%	4.62%	-17.38%	3.47%	5.64%	4.58%	5.09%	4.38%	1.14%
Tax Burden Percent	60.02%	81.26%	-10.78%	63.06%	95.36%	77.43%	80.08%	80.18%	77.66%	81.56%	107.63%
Interest Burden Percent	164.06%	75.39%	-324.54%	70.66%	-161.08%	49.97%	61.01%	63.48%	65.30%	61.25%	24.38%
Effective Tax Rate	0.00%	18.74%	0.00%	36.94%	0.00%	22.57%	19.92%	19.82%	22.34%	18.45%	-7.63%
Return on Invested Capital (ROIC)	-4.26%	8.27%	-0.03%	4.88%	6.87%	6.03%	8.19%	5.78%	6.54%	6.04%	3.84%
ROIC Less NNEP Spread (ROIC-NNEP)	-16.82%	2.47%	0.58%	1.76%	-49.73%	-1.68%	-0.68%	1.12%	1.37%	0.37%	-3.06%
Return on Net Nonoperating Assets (RNNOA)	-8.30%	1.41%	0.35%	1.05%	-31.29%	-1.09%	-0.38%	0.74%	1.09%	0.27%	-2.22%
Return on Equity (ROE)	-12.55%	9.68%	0.32%	5.93%	-24.42%	4.94%	7.81%	6.52%	7.63%	6.31%	1.62%
Cash Return on Invested Capital (CROIC)	20.59%	5.97%	5.25%	5.19%	30.39%	0.01%	6.54%	-7.00%	5.96%	7.15%	1.41%
Operating Return on Assets (OROA)	-4.69%	5.98%	0.36%	5.69%	6.57%	5.02%	6.68%	5.29%	6.07%	5.28%	2.59%
Return on Assets (ROA)	-4.62%	3.66%	0.13%	2.54%	-10.09%	1.94%	3.27%	2.69%	3.08%	2.64%	0.68%
Return on Common Equity (ROCE)	-12.55%	9.68%	0.32%	5.93%	-24.42%	4.94%	7.81%	6.52%	7.63%	6.31%	1.62%
Return on Equity Simple (ROE_SIMPLE)	-14.77%	9.77%	0.33%	5.92%	-28.55%	4.72%	7.44%	6.78%	7.45%	6.22%	0.00%
Net Operating Profit after Tax (NOPAT)	-139	240	-0.77	136	171	136	192	146	176	163	104
NOPAT Margin	-5.76%	10.15%	-0.03%	6.07%	7.97%	6.99%	9.20%	6.73%	7.83%	7.21%	4.68%
Net Nonoperating Expense Percent (NNEP)	12.57%	5.79%	-0.60%	3.12%	56.60%	7.71%	8.87%	4.66%	5.16%	5.67%	6.90%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	-	-	-	3.51%
Cost of Revenue to Revenue	51.11%	50.89%	51.01%	53.77%	54.85%	54.82%	54.43%	59.46%	58.22%	57.59%	58.40%
SG&A Expenses to Revenue	23.61%	17.47%	17.08%	17.68%	0.00%	20.97%	18.74%	17.92%	18.19%	19.08%	19.11%
R&D to Revenue	2.93%	3.04%	2.94%	2.73%	2.50%	2.84%	2.77%	2.56%	2.60%	2.59%	2.59%
Operating Expenses to Revenue	57.12%	36.61%	49.03%	36.60%	16.38%	36.15%	34.08%	32.15%	31.70%	33.56%	37.25%
Earnings before Interest and Taxes (EBIT)	-280	292	16	232	242	175	241	196	226	197	97
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-164	384	111	329	336	264	328	285	318	285	186
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	2.57	2.42	2.24	1.35	1.27	1.00	1.19	1.28	1.20	1.13	0.61
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	1.98	1.87	1.70	1.05	0.77	0.73	0.91	0.87	0.82	0.80	0.43
Price to Earnings (P/E)	0.00	24.73	685.73	22.80	2.91	21.14	16.05	18.89	16.12	18.17	37.24
Dividend Yield	48.29%	0.00%	0.00%	0.00%	0.00%	0.00%	1.72%	1.65%	1.65%	1.65%	2.95%
Earnings Yield	0.00%	4.04%	0.15%	4.39%	34.35%	4.73%	6.23%	5.29%	6.21%	5.50%	2.69%
Enterprise Value to Invested Capital (EV/IC)	2.02	1.88	1.78	1.22	1.16	1.00	1.13	1.15	1.11	1.08	0.78
Enterprise Value to Revenue (EV/Rev)	2.39	2.34	2.15	1.52	1.19	1.19	1.28	1.43	1.34	1.28	0.96
Enterprise Value to EBITDA (EV/EBITDA)	0.00	14.38	44.72	10.28	7.58	8.82	8.14	10.87	9.48	10.10	11.49
Enterprise Value to EBIT (EV/EBIT)	0.00	18.94	303.72	14.61	10.51	13.30	11.08	15.86	13.32	14.60	22.04
Enterprise Value to NOPAT (EV/NOPAT)	0.00	23.04	0.00	24.96	14.92	17.05	13.91	21.22	17.09	17.73	20.52
Enterprise Value to Operating Cash Flow (EV/OCF)	38.90	29.58	15.79	13.05	13.36	9.99	11.67	30.41	13.94	12.48	18.02
Enterprise Value to Free Cash Flow (EV/FCFF)	8.59	31.88	32.95	23.49	3.37	12,619.88	17.41	0.00	18.74	14.99	55.74
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.92	1.01	0.89	0.74	0.94	0.88	0.80	0.96	0.90	0.82	0.91
Long-Term Debt to Equity	0.91	0.84	0.88	0.63	0.84	0.86	0.78	0.95	0.88	0.80	0.89
Financial Leverage	0.49	0.57	0.60	0.59	0.63	0.65	0.56	0.66	0.79	0.72	0.73
Leverage Ratio	2.72	2.64	2.51	2.34	2.42	2.54	2.39	2.42	2.48	2.39	2.39
Compound Leverage Factor	4.46	1.99	-8.14	1.65	-3.90	1.27	1.46	1.54	1.62	1.46	0.58
Debt to Total Capital	47.93%	50.21%	47.00%	42.64%	48.53%	46.77%	44.31%	49.01%	47.26%	45.07%	47.63%
Short-Term Debt to Total Capital	0.49%	8.17%	0.59%	6.35%	5.19%	0.78%	0.93%	0.66%	0.67%	0.85%	0.99%
Long-Term Debt to Total Capital	47.44%	42.04%	46.41%	36.29%	43.35%	45.99%	43.38%	48.35%	46.59%	44.22%	46.64%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	52.07%	49.79%	53.00%	57.36%	51.47%	53.23%	55.69%	50.99%	52.74%	54.93%	52.37%
Debt to EBITDA	-10.44	4.80	13.95	3.94	3.66	4.78	3.84	4.94	4.35	4.55	7.61
Net Debt to EBITDA	-6.11	2.88	9.41	3.13	2.64	3.39	2.38	4.28	3.66	3.82	6.40
Long-Term Debt to EBITDA	-10.34	4.02	13.78	3.35	3.27	4.70	3.76	4.88	4.28	4.47	7.45
Debt to NOPAT	-12.31	7.69	-2,006.23	9.56	7.20	9.24	6.56	9.65	7.83	8.00	13.59
Net Debt to NOPAT	-7.20	4.61	-1,353.12	7.60	5.20	6.56	4.07	8.36	6.60	6.71	11.42
Long-Term Debt to NOPAT	-12.19	6.44	-1,981.04	8.14	6.43	9.08	6.42	9.52	7.72	7.84	13.31
Altman Z-Score	1.67	2.02	2.03	1.85	1.76	1.59	1.85	1.75	1.83	1.81	1.48
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.45	1.67	2.26	1.33	1.58	1.93	2.12	1.75	1.84	1.66	1.76
Quick Ratio	1.49	1.15	1.39	0.69	0.83	1.03	1.17	0.60	0.62	0.57	0.64
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	674	173	150	144	755	0.18	154	-177	161	192	38
Operating Cash Flow to CapEx	179.71%	268.78%	619.76%	452.71%	353.62%	0.00%	464.50%	198.44%	436.57%	408.85%	153.77%
Free Cash Flow to Firm to Interest Expense	6.76	2.41	2.17	2.12	12.06	0.00	1.63	-2.48	2.05	2.51	0.52
Operating Cash Flow to Interest Expense	1.49	2.60	4.53	3.81	3.04	2.66	2.44	1.43	2.75	3.02	1.62
Operating Cash Flow Less CapEx to Interest Expense	0.66	1.63	3.80	2.97	2.18	3.21	1.91	0.71	2.12	2.28	0.57
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.41	0.48	0.51	0.55	0.58	0.56	0.58	0.59	0.60	0.60	0.59
Accounts Receivable Turnover	6.25	8.74	9.48	9.92	9.91	10.70	13.49	15.10	18.52	20.91	17.99
Inventory Turnover	2.61	3.74	3.65	3.62	3.42	3.18	3.44	3.25	2.78	2.68	2.70
Fixed Asset Turnover	3.87	4.80	4.89	5.09	5.22	5.08	5.69	6.13	6.59	6.56	6.19
Accounts Payable Turnover	3.90	5.55	5.58	5.20	5.09	5.28	5.81	5.89	6.19	6.28	5.92
Days Sales Outstanding (DSO)	58.40	41.76	38.49	36.80	36.83	34.11	27.06	24.17	19.70	17.46	20.29
Days Inventory Outstanding (DIO)	140.07	97.47	100.04	100.71	106.71	114.63	105.99	112.37	131.11	136.34	135.20
Days Payable Outstanding (DPO)	93.51	65.80	65.39	70.17	71.67	69.10	62.87	61.95	58.92	58.17	61.70
Cash Conversion Cycle (CCC)	104.96	73.43	73.14	67.33	71.87	79.63	70.18	74.59	91.89	95.63	93.79
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	2,868	2,935	2,784	2,775	2,191	2,327	2,366	2,689	2,704	2,675	2,740
Invested Capital Turnover	0.74	0.81	0.80	0.80	0.86	0.86	0.89	0.86	0.84	0.84	0.82
Increase / (Decrease) in Invested Capital	-814	67	-151	-8.50	-584	136	39	323	16	-30	66
Enterprise Value (EV)	5,789	5,525	4,951	3,386	2,547	2,323	2,673	3,102	3,012	2,882	2,133
Market Capitalization	4,785	4,420	3,909	2,355	1,659	1,429	1,891	1,880	1,848	1,792	946
Book Value per Share	$29.97	$31.03	$30.57	$32.28	$24.07	$26.36	$29.14	$28.31	$30.32	$32.13	$33.43
Tangible Book Value per Share	($15.54)	($16.56)	($13.62)	($14.90)	($11.86)	($12.05)	($8.92)	($16.43)	($15.05)	($14.26)	($14.19)
Total Capital	3,580	3,674	3,287	3,042	2,533	2,692	2,845	2,878	2,921	2,884	2,966
Total Debt	1,716	1,845	1,545	1,297	1,229	1,259	1,261	1,410	1,380	1,300	1,413
Total Long-Term Debt	1,699	1,544	1,525	1,104	1,098	1,238	1,234	1,391	1,361	1,275	1,383
Net Debt	1,004	1,106	1,042	1,031	888	894	782	1,222	1,164	1,090	1,187
Capital Expenditures (CapEx)	83	70	51	57	54	-48	49	51	50	57	77
Debt-free, Cash-free Net Working Capital (DFCFNWC)	275	145	178	161	175	130	146	233	242	188	234
Debt-free Net Working Capital (DFNWC)	987	884	681	427	516	494	625	422	459	397	460
Net Working Capital (NWC)	970	584	662	234	385	473	599	403	439	372	430
Net Nonoperating Expense (NNE)	136	61	-6.47	32	543	69	74	47	62	64	79
Net Nonoperating Obligations (NNO)	1,004	1,106	1,042	1,031	888	894	782	1,222	1,164	1,090	1,187
Total Depreciation and Amortization (D&A)	115	93	94	98	94	89	87	90	91	88	89
Debt-free, Cash-free Net Working Capital to Revenue	11.37%	6.15%	7.76%	7.20%	8.16%	6.64%	7.00%	10.73%	10.75%	8.33%	10.52%
Debt-free Net Working Capital to Revenue	40.78%	37.43%	29.64%	19.12%	24.11%	25.35%	29.96%	19.42%	20.36%	17.61%	20.67%
Net Working Capital to Revenue	40.05%	24.72%	28.79%	10.48%	17.97%	24.27%	28.69%	18.54%	19.50%	16.52%	19.34%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($4.44)	$3.02	$0.10	$1.90	($6.88)	$1.25	$2.15	$1.86	$2.24	$1.98	$0.53
Adjusted Weighted Average Basic Shares Outstanding	60.03M	57.91M	56.02M	54.04M	54.21M	54.36M	54.37M	51.44M	50.02M	48.72M	47.50M
Adjusted Diluted Earnings per Share	($4.44)	$2.99	$0.10	$1.90	($6.88)	$1.24	$2.12	$1.84	$2.21	$1.97	$0.53
Adjusted Weighted Average Diluted Shares Outstanding	60.03M	57.91M	56.02M	54.04M	54.21M	54.36M	54.37M	51.44M	50.02M	48.72M	47.60M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	60.03M	57.91M	56.02M	54.04M	54.21M	54.36M	54.37M	51.44M	50.02M	48.72M	46.46M
Normalized Net Operating Profit after Tax (NOPAT)	122	275	243	179	203	155	209	158	189	192	137
Normalized NOPAT Margin	5.03%	11.65%	10.58%	8.00%	9.49%	7.97%	10.00%	7.30%	8.40%	8.51%	6.16%
Pre Tax Income Margin	-18.95%	9.31%	-2.30%	7.33%	-18.23%	4.48%	7.05%	5.71%	6.56%	5.36%	1.06%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-2.80	4.06	0.24	3.41	3.87	2.00	2.56	2.74	2.88	2.58	1.32
NOPAT to Interest Expense	-1.40	3.34	-0.01	1.99	2.73	1.56	2.04	2.05	2.25	2.12	1.42
EBIT Less CapEx to Interest Expense	-3.63	3.09	-0.50	2.57	3.01	2.55	2.04	2.02	2.25	1.84	0.27
NOPAT Less CapEx to Interest Expense	-2.23	2.37	-0.74	1.15	1.87	2.11	1.52	1.33	1.62	1.39	0.37
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	-33.85%	0.00%	0.00%	0.00%	0.00%	0.00%	21.73%	32.76%	27.46%	31.14%	115.35%
Augmented Payout Ratio	-97.49%	110.02%	2,901.75%	120.43%	0.00%	0.00%	29.54%	158.69%	93.03%	90.47%	470.47%

This table displays calculated financial ratios and metrics derived from Edgewell Personal Care's official financial filings.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	4.20%	-0.52%	4.22%	0.17%	-0.34%	-3.09%	-2.15%	-3.12%	-3.18%	3.79%	1.86%
EBITDA Growth	46.48%	-11.83%	-18.69%	27.56%	-8.44%	-41.17%	-19.67%	-7.24%	-23.59%	-134.31%	-86.69%
EBIT Growth	65.75%	-16.93%	-30.08%	42.49%	-9.67%	-55.96%	-33.72%	-8.75%	-30.38%	-267.69%	-388.52%
NOPAT Growth	53.91%	2.15%	-10.26%	29.61%	0.48%	-28.94%	-31.94%	-22.97%	-35.21%	-176.43%	-303.23%
Net Income Growth	73.77%	-13.58%	-61.29%	85.57%	-7.55%	-70.57%	-143.75%	-19.44%	-40.61%	-447.73%	-3,028.57%
EPS Growth	78.95%	-10.77%	-62.50%	94.59%	-3.92%	-68.97%	-144.44%	-16.67%	-36.73%	-461.11%	-3,425.00%
Operating Cash Flow Growth	48.17%	61.49%	15.53%	46.26%	-39.18%	54.18%	-58.57%	-65.04%	13.44%	119.08%	-8.91%
Free Cash Flow Firm Growth	117.57%	111.28%	-103.57%	-195.26%	9.00%	101.55%	9,165.63%	98.76%	-152.58%	-244.52%	1,293.10%
Invested Capital Growth	0.46%	0.58%	0.76%	0.00%	0.29%	-1.10%	-0.53%	2.73%	2.67%	2.46%	-11.10%
Revenue Q/Q Growth	8.62%	-17.83%	-8.46%	22.60%	8.07%	-20.10%	-7.57%	21.38%	8.01%	-14.35%	-21.30%
EBITDA Q/Q Growth	59.80%	-33.07%	-35.86%	85.92%	14.70%	-56.99%	-12.42%	114.69%	-5.52%	-119.31%	124.34%
EBIT Q/Q Growth	90.27%	-42.22%	-50.38%	161.24%	20.62%	-71.83%	-25.33%	259.65%	-7.97%	-167.84%	54.17%
NOPAT Q/Q Growth	55.77%	-27.50%	-55.37%	157.15%	20.75%	-48.73%	-57.26%	191.05%	1.57%	-160.49%	47.93%
Net Income Q/Q Growth	173.20%	-43.58%	-83.95%	650.00%	36.11%	-82.04%	-123.86%	1,480.95%	0.34%	-205.15%	-114.71%
EPS Q/Q Growth	175.68%	-43.14%	-84.48%	700.00%	36.11%	-81.63%	-122.22%	1,600.00%	3.33%	-204.84%	-116.92%
Operating Cash Flow Q/Q Growth	88.66%	-71.27%	-252.51%	276.95%	-21.55%	-27.17%	-256.85%	139.01%	154.55%	-35.45%	-269.91%
Free Cash Flow Firm Q/Q Growth	-98.14%	-40.22%	-101.02%	-836,089.49%	102.13%	10.53%	-53.98%	-214.59%	9.77%	-203.77%	425.84%
Invested Capital Q/Q Growth	0.00%	0.74%	3.84%	-2.80%	-1.36%	-0.66%	4.44%	0.39%	-1.42%	-0.87%	-9.38%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	43.12%	42.80%	40.44%	43.06%	44.32%	41.11%	40.05%	44.12%	42.81%	38.83%	38.08%
EBITDA Margin	17.31%	14.10%	9.88%	14.98%	15.90%	8.56%	8.11%	14.34%	12.55%	-2.83%	0.88%
Operating Margin	13.26%	9.75%	5.34%	11.70%	12.77%	3.94%	4.24%	10.14%	8.56%	-6.76%	-4.47%
EBIT Margin	13.85%	9.74%	5.28%	11.24%	12.55%	4.42%	3.57%	10.59%	9.02%	-7.15%	-4.16%
Profit (Net Income) Margin	8.15%	5.60%	0.98%	6.01%	7.56%	1.70%	-0.44%	4.99%	4.64%	-5.70%	-15.54%
Tax Burden Percent	74.86%	89.79%	80.00%	76.60%	78.40%	162.96%	123.53%	70.22%	78.23%	57.52%	178.05%
Interest Burden Percent	78.67%	64.04%	23.26%	69.73%	76.88%	23.58%	-9.94%	67.15%	65.72%	138.54%	209.66%
Effective Tax Rate	25.14%	10.21%	20.00%	23.40%	21.60%	-62.96%	0.00%	29.78%	21.77%	0.00%	0.00%
Return on Invested Capital (ROIC)	8.36%	7.31%	3.47%	14.92%	8.45%	5.38%	2.38%	5.73%	5.41%	-3.88%	-2.65%
ROIC Less NNEP Spread (ROIC-NNEP)	7.37%	5.90%	2.20%	11.91%	7.04%	3.21%	1.10%	4.72%	4.29%	-4.34%	-7.23%
Return on Net Nonoperating Assets (RNNOA)	5.66%	4.68%	1.83%	9.05%	5.07%	2.32%	0.92%	3.80%	3.16%	-3.15%	-5.54%
Return on Equity (ROE)	14.02%	11.99%	5.30%	23.96%	13.52%	7.70%	3.30%	9.53%	8.57%	-7.04%	-8.19%
Cash Return on Invested Capital (CROIC)	6.10%	5.96%	5.44%	-186.47%	6.62%	7.15%	6.13%	2.50%	1.79%	1.41%	13.57%
Operating Return on Assets (OROA)	8.34%	5.88%	3.16%	6.80%	7.62%	2.67%	2.14%	6.26%	5.30%	-4.25%	-2.49%
Return on Assets (ROA)	4.91%	3.38%	0.59%	3.63%	4.59%	1.03%	-0.26%	2.95%	2.73%	-3.38%	-9.28%
Return on Common Equity (ROCE)	14.02%	11.99%	5.30%	23.96%	13.52%	7.70%	3.30%	9.53%	8.57%	-7.04%	-8.19%
Return on Equity Simple (ROE_SIMPLE)	7.70%	0.00%	6.93%	7.97%	7.59%	0.00%	6.11%	5.59%	0.00%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	65	47	21	54	65	33	14	41	42	-25	-13
NOPAT Margin	9.93%	8.76%	4.27%	8.96%	10.01%	6.42%	2.97%	7.12%	6.70%	-4.73%	-3.13%
Net Nonoperating Expense Percent (NNEP)	0.99%	1.42%	1.27%	3.00%	1.41%	2.17%	1.28%	1.00%	1.12%	0.46%	4.58%
Return On Investment Capital (ROIC_SIMPLE)	-	-	0.69%	-	-	-	0.48%	1.39%	1.42%	-0.86%	-0.44%
Cost of Revenue to Revenue	56.88%	57.20%	59.56%	56.94%	55.68%	58.89%	59.95%	55.88%	57.19%	61.17%	61.92%
SG&A Expenses to Revenue	14.82%	21.04%	21.13%	17.93%	17.00%	21.10%	21.51%	18.20%	16.65%	20.85%	24.22%
R&D to Revenue	2.28%	2.98%	2.72%	2.37%	2.25%	3.15%	2.91%	2.39%	2.23%	2.94%	3.26%
Operating Expenses to Revenue	29.86%	33.05%	35.10%	31.36%	31.55%	37.17%	35.81%	33.98%	34.25%	45.59%	42.55%
Earnings before Interest and Taxes (EBIT)	90	52	26	67	81	23	17	62	57	-38	-18
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	113	75	48	90	103	44	39	83	79	-15	3.70
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.34	1.20	1.19	1.24	1.26	1.13	1.12	0.99	0.70	0.61	0.56
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	0.92	0.82	0.81	0.85	0.88	0.80	0.75	0.68	0.50	0.43	0.37
Price to Earnings (P/E)	17.42	16.12	17.11	15.54	16.64	18.17	18.36	17.77	16.99	37.24	0.00
Dividend Yield	1.48%	1.65%	1.66%	1.56%	1.49%	1.65%	1.79%	1.92%	2.56%	2.95%	3.52%
Earnings Yield	5.74%	6.21%	5.84%	6.44%	6.01%	5.50%	5.45%	5.63%	5.89%	2.69%	0.00%
Enterprise Value to Invested Capital (EV/IC)	1.20	1.11	1.10	1.14	1.15	1.08	1.07	1.00	0.83	0.78	0.87
Enterprise Value to Revenue (EV/Rev)	1.43	1.34	1.36	1.36	1.37	1.28	1.33	1.26	1.04	0.96	0.97
Enterprise Value to EBITDA (EV/EBITDA)	9.81	9.48	10.10	9.51	9.82	10.10	10.79	10.38	9.37	11.49	13.40
Enterprise Value to EBIT (EV/EBIT)	13.57	13.32	14.39	13.18	13.72	14.60	15.77	15.29	14.53	22.04	29.60
Enterprise Value to NOPAT (EV/NOPAT)	18.29	17.09	17.86	16.79	16.72	17.73	18.99	19.46	19.01	20.52	45.20
Enterprise Value to Operating Cash Flow (EV/OCF)	16.24	13.94	13.48	11.47	15.15	12.48	15.81	26.78	19.47	18.02	20.02
Enterprise Value to Free Cash Flow (EV/FCFF)	19.66	18.74	20.35	0.00	17.45	14.99	17.35	40.49	47.03	55.74	6.05
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.86	0.90	0.96	0.89	0.83	0.82	0.98	0.96	0.89	0.91	1.05
Long-Term Debt to Equity	0.85	0.88	0.94	0.87	0.82	0.80	0.96	0.95	0.88	0.89	1.02
Financial Leverage	0.77	0.79	0.83	0.76	0.72	0.72	0.84	0.81	0.74	0.73	0.77
Leverage Ratio	2.47	2.48	2.48	2.42	2.39	2.39	2.46	2.46	2.39	2.39	2.50
Compound Leverage Factor	1.94	1.59	0.58	1.69	1.84	0.56	-0.24	1.65	1.57	3.31	5.24
Debt to Total Capital	46.36%	47.26%	48.85%	46.98%	45.42%	45.07%	49.44%	49.10%	47.10%	47.63%	51.10%
Short-Term Debt to Total Capital	0.61%	0.67%	0.80%	0.81%	0.74%	0.85%	0.92%	0.91%	0.78%	0.99%	1.07%
Long-Term Debt to Total Capital	45.75%	46.59%	48.05%	46.17%	44.68%	44.22%	48.52%	48.18%	46.31%	46.64%	50.03%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	53.64%	52.74%	51.15%	53.02%	54.58%	54.93%	50.56%	50.90%	52.90%	52.37%	48.90%
Debt to EBITDA	4.09	4.35	4.82	4.22	4.15	4.55	5.32	5.42	5.70	7.61	9.62
Net Debt to EBITDA	3.46	3.66	4.12	3.62	3.53	3.82	4.68	4.79	4.88	6.40	8.24
Long-Term Debt to EBITDA	4.04	4.28	4.74	4.14	4.08	4.47	5.22	5.32	5.60	7.45	9.42
Debt to NOPAT	7.63	7.83	8.52	7.44	7.06	8.00	9.36	10.17	11.55	13.59	32.44
Net Debt to NOPAT	6.45	6.60	7.28	6.38	6.00	6.71	8.24	8.98	9.90	11.42	27.78
Long-Term Debt to NOPAT	7.53	7.72	8.38	7.32	6.94	7.84	9.19	9.98	11.36	13.31	31.76
Altman Z-Score	1.74	1.68	1.66	1.72	1.79	1.65	1.65	1.60	1.48	1.36	1.35
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.71	1.84	2.15	1.84	1.79	1.66	2.06	1.89	1.77	1.76	2.12
Quick Ratio	0.57	0.62	0.70	0.60	0.66	0.57	0.64	0.65	0.62	0.64	0.76
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	52	31	-0.32	-2,676	57	63	29	-33	-30	-91	297
Operating Cash Flow to CapEx	1,352.85%	259.78%	-1,121.54%	1,121.74%	803.17%	284.56%	-688.10%	263.74%	740.65%	268.48%	-1,085.34%
Free Cash Flow to Firm to Interest Expense	2.73	1.67	-0.02	-131.17	3.03	3.60	1.54	-1.65	-1.55	-6.16	15.38
Operating Cash Flow to Interest Expense	8.67	2.56	-3.68	6.32	5.38	4.21	-6.15	2.23	5.92	5.01	-6.52
Operating Cash Flow Less CapEx to Interest Expense	8.03	1.57	-4.01	5.76	4.71	2.73	-7.04	1.39	5.12	3.14	-7.12
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.60	0.60	0.60	0.61	0.61	0.60	0.60	0.59	0.59	0.59	0.60
Accounts Receivable Turnover	16.29	18.52	16.62	17.40	16.42	20.91	19.25	14.41	14.30	17.99	16.26
Inventory Turnover	2.89	2.78	2.49	2.63	2.71	2.68	2.53	2.53	2.70	2.70	2.74
Fixed Asset Turnover	6.56	6.59	6.72	6.94	6.83	6.56	6.63	6.62	6.47	6.19	7.03
Accounts Payable Turnover	5.51	6.19	5.98	5.95	5.77	6.28	6.45	5.87	5.89	5.92	6.32
Days Sales Outstanding (DSO)	22.40	19.70	21.96	20.98	22.23	17.46	18.96	25.33	25.52	20.29	22.45
Days Inventory Outstanding (DIO)	126.51	131.11	146.61	138.55	134.68	136.34	144.39	144.16	135.19	135.20	133.34
Days Payable Outstanding (DPO)	66.29	58.92	61.08	61.32	63.21	58.17	56.62	62.22	62.02	61.70	57.74
Cash Conversion Cycle (CCC)	82.62	91.89	107.49	98.21	93.70	95.63	106.74	107.28	98.69	93.79	98.05
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	2,685	2,704	2,808	2,730	2,692	2,675	2,793	2,804	2,764	2,740	2,483
Invested Capital Turnover	0.84	0.84	0.81	1.67	0.84	0.84	0.80	0.80	0.81	0.82	0.85
Increase / (Decrease) in Invested Capital	12	16	21	2,730	7.80	-30	-15	75	72	66	-310
Enterprise Value (EV)	3,214	3,012	3,095	3,100	3,107	2,882	2,976	2,795	2,297	2,133	2,164
Market Capitalization	2,080	1,848	1,832	1,922	1,992	1,792	1,684	1,505	1,101	946	834
Book Value per Share	$30.31	$30.32	$30.85	$31.07	$31.82	$32.13	$30.82	$31.39	$33.34	$33.43	$30.38
Tangible Book Value per Share	($15.02)	($15.05)	($15.20)	($14.88)	($14.30)	($14.26)	($15.65)	($15.53)	($14.97)	($14.19)	($9.67)
Total Capital	2,892	2,921	3,022	2,926	2,888	2,884	2,969	2,974	2,964	2,966	3,040
Total Debt	1,341	1,380	1,477	1,374	1,312	1,300	1,468	1,460	1,396	1,413	1,553
Total Long-Term Debt	1,323	1,361	1,452	1,351	1,290	1,275	1,441	1,433	1,373	1,383	1,521
Net Debt	1,133	1,164	1,262	1,178	1,116	1,090	1,292	1,290	1,196	1,187	1,330
Capital Expenditures (CapEx)	12	18	6.50	12	13	26	17	17	16	28	12
Debt-free, Cash-free Net Working Capital (DFCFNWC)	219	242	348	280	249	188	338	333	261	234	369
Debt-free Net Working Capital (DFNWC)	427	459	562	477	445	397	513	503	461	460	592
Net Working Capital (NWC)	409	439	538	453	424	372	486	476	437	430	560
Net Nonoperating Expense (NNE)	12	17	16	18	16	24	16	12	13	5.19	52
Net Nonoperating Obligations (NNO)	1,133	1,164	1,262	1,178	1,116	1,090	1,292	1,290	1,196	1,187	997
Total Depreciation and Amortization (D&A)	23	23	23	22	22	21	22	22	22	23	21
Debt-free, Cash-free Net Working Capital to Revenue	9.72%	10.75%	15.31%	12.34%	10.96%	8.33%	15.06%	14.98%	11.84%	10.52%	16.53%
Debt-free Net Working Capital to Revenue	18.92%	20.36%	24.74%	20.97%	19.60%	17.61%	22.89%	22.63%	20.89%	20.67%	26.54%
Net Working Capital to Revenue	18.13%	19.50%	23.68%	19.93%	18.66%	16.52%	21.67%	21.40%	19.84%	19.34%	25.08%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$1.03	$0.58	$0.10	$0.72	$0.99	$0.17	($0.04)	$0.60	$0.62	($0.65)	($1.41)
Adjusted Weighted Average Basic Shares Outstanding	50.81M	50.02M	49.93M	49.55M	49.31M	48.72M	48.70M	48M	46.80M	47.50M	46.60M
Adjusted Diluted Earnings per Share	$1.01	$0.58	$0.09	$0.72	$0.98	$0.18	($0.04)	$0.60	$0.62	($0.65)	($1.41)
Adjusted Weighted Average Diluted Shares Outstanding	50.81M	50.02M	49.93M	49.55M	49.31M	48.72M	48.70M	48.20M	47M	47.60M	46.60M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	50.81M	50.02M	49.93M	49.55M	49.31M	48.72M	48.23M	47.03M	46.46M	46.46M	46.72M
Normalized Net Operating Profit after Tax (NOPAT)	67	54	26	56	67	30	17	50	55	-15	-0.56
Normalized NOPAT Margin	10.27%	10.09%	5.38%	9.37%	10.38%	5.84%	3.58%	8.60%	8.69%	-2.71%	-0.13%
Pre Tax Income Margin	10.89%	6.23%	1.23%	7.84%	9.65%	1.04%	-0.36%	7.11%	5.93%	-9.90%	-8.73%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	4.69	2.78	1.30	3.30	4.32	1.31	0.91	3.04	2.92	-2.59	-0.91
NOPAT to Interest Expense	3.36	2.50	1.05	2.63	3.45	1.90	0.76	2.05	2.17	-1.72	-0.69
EBIT Less CapEx to Interest Expense	4.05	1.80	0.97	2.74	3.65	-0.17	0.02	2.20	2.12	-4.46	-1.51
NOPAT Less CapEx to Interest Expense	2.72	1.52	0.73	2.07	2.78	0.42	-0.14	1.20	1.37	-3.58	-1.29
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	26.55%	27.46%	28.76%	25.22%	25.90%	31.14%	33.81%	35.54%	45.99%	115.35%	-75.39%
Augmented Payout Ratio	77.14%	93.03%	98.97%	86.26%	84.54%	90.47%	114.29%	146.40%	213.43%	470.47%	-232.20%

Financials Breakdown Chart

Key Financial Trends

Here are the key takeaways from Edgewell Personal Care (NYSE:EPC) based on quarterly results over the last four years, focusing on trends that may matter to retail investors.

Revenue resilience: Edgewell has hovered in the mid-to-high 500s million per quarter, with a notable peak of 627.2 million in Q3 2025, suggesting ongoing demand for its consumer brands.
Gross margin stability: Gross margins have generally run in the 40% to 45% range (e.g., ~42%+ in several quarters), indicating relatively stable product profitability despite mix and pricing dynamics.
Consistent pockets of profitability: Several quarters posted positive net income (e.g., Q3 2024 at ~52.9 million; Q2 2025 at ~29.0 million; Q3 2025 at ~29.1 million), signaling improving earnings under certain conditions.
Operating cash flow was positive in multiple periods: Notably, Q3 2025 produced about 114.8 million from continuing operating activities, and Q4 2024 generated roughly 73.7 million, indicating periods of solid cash generation.
Dividends maintained: A cash dividend of 0.15 per share is being paid, reflecting ongoing capital return to shareholders.
Restatements and data revisions: The earnings history includes quarters labeled as restated or calculated in the data, which can affect comparability across periods.
Working capital and seasonality: Inventories and working capital levels show quarter-to-quarter variation typical for consumer staples, reflecting seasonality and category mix rather than a single directional trend.
Steady asset base with manageable scale: Total assets have typically ranged in the low-to-mid 3s billions (about 3.7–3.8b in many periods), suggesting a stable balance-sheet size over the four-year window.
Significant leverage and debt service: Long-term debt around 1.5 billion and total liabilities near 2.28 billion as of mid-late 2020s, plus ongoing interest expenses in the teens to low 20 millions per quarter, implying meaningful debt service burden.
Near-term profitability and cash-flow swings: In some recent quarters, net income turned negative (e.g., Q1 2026 shows a net loss of about 65.7 million) and cash flow from operations also turned negative (e.g., net cash from continuing operating activities around -125.9 million), highlighting volatility and potential near-term earnings and liquidity pressure.

05/07/26 01:45 AM ETAI Generated. May Contain Errors.

Frequently Asked Questions About Edgewell Personal Care's Financials

When does Edgewell Personal Care's financial year end?

According to the most recent income statement we have on file, Edgewell Personal Care's fiscal year ends in September. Their fiscal year 2025 ended on September 30, 2025.

How has Edgewell Personal Care's net income changed over the last 10 years?

Edgewell Personal Care's net income appears to be on an upward trend, with a most recent value of $25.40 million in 2025, falling from -$275.30 million in 2015. The previous period was $98.60 million in 2024. Check out Edgewell Personal Care's forecast to explore projected trends and price targets.

What is Edgewell Personal Care's operating income?

Edgewell Personal Care's total operating income in 2025 was $96.60 million, based on the following breakdown:

Total Gross Profit: $924.90 million
Total Operating Expenses: $828.30 million

How has Edgewell Personal Care's revenue changed over the last 10 years?

Over the last 10 years, Edgewell Personal Care's total revenue changed from $2.42 billion in 2015 to $2.22 billion in 2025, a change of -8.2%.

How much debt does Edgewell Personal Care have?

Edgewell Personal Care's total liabilities were at $2.20 billion at the end of 2025, a 2.6% increase from 2024, and a 29.4% decrease since 2015.

How much cash does Edgewell Personal Care have?

In the past 10 years, Edgewell Personal Care's cash and equivalents has ranged from $188.70 million in 2022 to $738.90 million in 2016, and is currently $225.70 million as of their latest financial filing in 2025.

How has Edgewell Personal Care's book value per share changed over the last 10 years?

Over the last 10 years, Edgewell Personal Care's book value per share changed from 29.97 in 2015 to 33.43 in 2025, a change of 11.5%.

Related Companies

Financial statements for NYSE:EPC last updated on 2/12/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Edgewell Personal Care (EPC) Financials

Financials Breakdown Chart

Key Financial Trends

Frequently Asked Questions About Edgewell Personal Care's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Edgewell Personal Care (EPC) Financials

Annual Income Statements for Edgewell Personal Care

Quarterly Income Statements for Edgewell Personal Care

Annual Cash Flow Statements for Edgewell Personal Care

Quarterly Cash Flow Statements for Edgewell Personal Care

Annual Balance Sheets for Edgewell Personal Care

Quarterly Balance Sheets for Edgewell Personal Care

Annual Metrics And Ratios for Edgewell Personal Care

Quarterly Metrics And Ratios for Edgewell Personal Care

Financials Breakdown Chart

Key Financial Trends

Frequently Asked Questions About Edgewell Personal Care's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools